Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/45822
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12115]
Metadata
Show full item record
EARLY TRANSMISSION OF SARS-COV-2 IN SOUTH AFRICA: AN EPIDEMIOLOGICAL AND PHYLOGENETIC REPORT
África do Sul
Epidemiologia
Sequenciamento da próxima geração
Phylogenetic
Genômica de transmissão
COVID-19
South Africa
NGS-SA
Next Generation Sequencing
Epidemiology
Phylogenetic
Transmission genomics
COVID-19
Author
Giandhari, Jennifer
Pillay, Sureshnee
Wilkinson, Eduan
Tegally, Houriiyah
Sinayskiy, Ilya
Schuld, Maria
Lourenço, José
Chimukangara, Benjamin
Lessels, Richard
Moosa, Yunus
Gazy, Inbal
Fish, Maryam
Singh, Lavanya
Khanyile, Khulekani Sedwell
Fonseca, Vagner
Giovanetti, Marta
Alcantara, Luiz Carlos Junior
Petruccione, Francesco
Oliveira, Tulio de
Pillay, Sureshnee
Wilkinson, Eduan
Tegally, Houriiyah
Sinayskiy, Ilya
Schuld, Maria
Lourenço, José
Chimukangara, Benjamin
Lessels, Richard
Moosa, Yunus
Gazy, Inbal
Fish, Maryam
Singh, Lavanya
Khanyile, Khulekani Sedwell
Fonseca, Vagner
Giovanetti, Marta
Alcantara, Luiz Carlos Junior
Petruccione, Francesco
Oliveira, Tulio de
Affilliation
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Chemistry and Physics. Quantum Research Group. Durban, South Africa / National Institute for Theoretical Physics (NITheP). KwaZulu-Natal, South Africa.
University of KwaZulu-Natal. School of Chemistry and Physics. Quantum Research Group. Durban, South Africa.
University of Oxford. Department of Zoology. Oxford, UK.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa / University of Oxford. Department of Zoology. Oxford, UK.
University of Oxford. Department of Zoology. Oxford, UK.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa / Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Laboratório de Genética Celular e Molecular. Belo Horizonte, MG, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Laboratório de Genética Celular e Molecular. Belp Horizonte, MG, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
University of KwaZulu-Natal. School of Chemistry and Physics. Quantum Research Group. Durban, South Africa / National Institute for Theoretical Physics (NITheP). KwaZulu-Natal, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa / Centre for Aids Programme of Research in South Africa (CAPRISA). Durban, South Africa / University of Washington. Department of Global Health. Seattle, Washington, USA.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Chemistry and Physics. Quantum Research Group. Durban, South Africa / National Institute for Theoretical Physics (NITheP). KwaZulu-Natal, South Africa.
University of KwaZulu-Natal. School of Chemistry and Physics. Quantum Research Group. Durban, South Africa.
University of Oxford. Department of Zoology. Oxford, UK.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa / University of Oxford. Department of Zoology. Oxford, UK.
University of Oxford. Department of Zoology. Oxford, UK.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa / Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Laboratório de Genética Celular e Molecular. Belo Horizonte, MG, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Laboratório de Genética Celular e Molecular. Belp Horizonte, MG, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
University of KwaZulu-Natal. School of Chemistry and Physics. Quantum Research Group. Durban, South Africa / National Institute for Theoretical Physics (NITheP). KwaZulu-Natal, South Africa.
University of KwaZulu-Natal. School of Laboratory Medicine & Medical Sciences. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP). Durban, South Africa / Centre for Aids Programme of Research in South Africa (CAPRISA). Durban, South Africa / University of Washington. Department of Global Health. Seattle, Washington, USA.
Abstract
Objectives: The Network for Genomic Surveillance in South Africa (NGS-SA) was formed to investigate the
introduction and understand the early transmission dynamics of the SARS-CoV-2 epidemic in South-
Africa.
Design: This paper presents the
first results from this group, which is a molecular epidemiological study
of the
first 21 SARS-CoV-2 whole genomes sampled in the
first port of entry – KwaZulu-Natal (KZN) –
during the
first month of the epidemic. By combining this with calculations of the effective reproduction
number (R), it aimed to shed light on the patterns of infections in South Africa.
Results: Two of the largest provinces – Gauteng and KZN – had a slow growth rate for the number of
detected cases, while the epidemic spread faster in the Western Cape and Eastern Cape. The estimates of
transmission potential suggested a decrease towards R = 1 since the
first cases and deaths, but a
subsequent estimated R average of 1.39 between 6–18 May 2020. It was also demonstrated that early
transmission in KZN was associated with multiple international introductions and dominated by lineages
B1 and B. Evidence for locally acquired infections in a hospital in Durban within the
first month of the
epidemic was also provided.
Conclusion: The COVID-19 pandemic in South Africa was very heterogeneous in its spatial dimension,
with many distinct introductions of SARS-CoV2 in KZN and evidence of nosocomial transmission, which
inflated early mortality in KZN. The epidemic at the local level was still developing and NGS-SA aimed to
clarify the dynamics in South Africa and devise the most effective measures as the outbreak evolved.
© 2020 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Keywords in Portuguese
SARS-CoV-2África do Sul
Epidemiologia
Sequenciamento da próxima geração
Phylogenetic
Genômica de transmissão
COVID-19
Keywords
SARS-CoV-2South Africa
NGS-SA
Next Generation Sequencing
Epidemiology
Phylogenetic
Transmission genomics
COVID-19
Share